Trademark Overview
On Monday, August 4, 2025, a trademark application was filed for MIRVEL with the United States Patent and Trademark Office. The USPTO has given the MIRVEL trademark a serial number of 79433446. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 25, 2025. This trademark is owned by Lexogen GmbH. The MIRVEL trademark is filed in the Chemical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:
Laboratory instruments, other than for medical purposes, namely automated micro- and macrofluidic instruments for the isolation, preparation, labelling, replication or screening of genetic material or RNA.
Chemical and biochemical substances for biotechnological purposes, in particular for molecular biological use for the treatment of RNA (ribonucleic acid), as well as for reagent kits for industrial and scientific purposes, in particular for RNA treatment; chemical substances for laboratory analysis and for use in kits; diagnostic reagents for in vitro applications in clinical chemistry; enzymes, other than for medical and veterinary purposes, in particular for use in kits and for use in carrying out DNA labelling, DNA amplification, DNA analysis or RNA labelling, RNA amplification, RNA analysis and for enzyme preparations.
Scientific and technological services, in particular scientific research, development, diagnostics and analysis in the field of molecular biological use for the treatment of RNA (ribonucleic acid); scientific and technological services, in particular scientific research, development, diagnostics and analysis in the field of diagnostic chemicals and reagents; scientific and technological services for RNA separation, RNA purification, RNA isolation, RNA labeling, RNA amplification; scientific and technological services, namely scientific analysis in the field of research, development and diagnostics relating to genomics, transcriptomics, proteomics and genetic engineering.